ID: ALA4579511

Max Phase: Preclinical

Molecular Formula: C18H16N4S

Molecular Weight: 320.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1ccc(Cn2c(NCc3nccs3)nc3ccccc32)cc1

Standard InChI:  InChI=1S/C18H16N4S/c1-2-6-14(7-3-1)13-22-16-9-5-4-8-15(16)21-18(22)20-12-17-19-10-11-23-17/h1-11H,12-13H2,(H,20,21)

Standard InChI Key:  LBNDIULXAWKQIH-UHFFFAOYSA-N

Associated Targets(non-human)

Short transient receptor potential channel 5 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 320.42Molecular Weight (Monoisotopic): 320.1096AlogP: 4.15#Rotatable Bonds: 5
Polar Surface Area: 42.74Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.42CX LogP: 3.82CX LogD: 3.78
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.60Np Likeness Score: -1.91

References

1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR..  (2019)  Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.,  29  (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007]

Source